Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. A new government study reviewing past research on the safety of ...
Median (range) 6.2 (2.3-15.0) 4.5 (2.0-13.7) 4.3 (0.2-14.1) NOTE. Data are No. (%) unless indicated otherwise. The intention-to-treat analysis set included all patients who underwent random assignment ...
Objective To examine and summarise evidence from meta-analyses of cohort studies that evaluated the predictive associations between baseline cardiorespiratory fitness (CRF) and health outcomes among ...
Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain.
Uncovering important nuances in frequency, motivation, and impact that you might not expect.